Expert US stock credit rating analysis and default risk assessment to identify financial distress signals. We monitor credit markets to understand the health of companies and potential risks to equity holders.
As of 2026-04-13, The Beauty Health Company (SKIN) trades at a current price of $0.88, marking a 1.54% decline from the previous session’s close. This analysis evaluates key technical levels, recent sector context, and potential short-term price scenarios for SKIN, with no company-specific material news driving price action in recent sessions. No recent earnings data is available for the company at the time of writing, so near-term price movements are primarily tied to technical trading patterns
Is The Beauty (SKIN) Stock in a Selling Zone | Price at $0.88, Down 1.54% - Analyst Upgrade
SKIN - Stock Analysis
3205 Comments
1485 Likes
1
Alinson
Regular Reader
2 hours ago
Incredible work, where’s the autograph line? 🖊️
👍 251
Reply
2
Nolene
Power User
5 hours ago
If only I had spotted this sooner.
👍 209
Reply
3
Alisha
Power User
1 day ago
Expert US stock management team analysis and board composition review for governance quality assessment. We analyze leadership track record and board effectiveness to understand the quality of decision-makers at your portfolio companies.
👍 28
Reply
4
Cinco
New Visitor
1 day ago
I read this and now I can’t unsee it.
👍 133
Reply
5
Mykenna
Daily Reader
2 days ago
Volatility remains moderate, with indices fluctuating around key moving averages. This reflects a balanced market where both buying and selling pressures coexist. Analysts point out that sustained strength above current support levels could signal further upside, while a sudden breakdown might trigger short-term corrections that could offer buying opportunities.
👍 151
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.